Knoll Capital Management as of March 31, 2017
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 17 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 46.5 | $31M | 3.7M | 8.25 | |
| Abeona Therapeutics | 17.7 | $12M | 2.4M | 4.98 | |
| Vascular Biogenics | 7.1 | $4.7M | 861k | 5.50 | |
| Anavex Life Sciences (AVXL) | 6.3 | $4.2M | 724k | 5.74 | |
| Newlink Genetics Corporation | 3.4 | $2.3M | 94k | 24.10 | |
| Ampio Pharmaceuticals | 3.3 | $2.2M | 2.7M | 0.80 | |
| Volitionrx (VNRX) | 2.8 | $1.9M | 462k | 4.02 | |
| Alcobra | 2.1 | $1.4M | 1.2M | 1.14 | |
| Summit Therapeutics Plc spons ads | 2.0 | $1.3M | 100k | 13.27 | |
| Keryx Biopharmaceuticals | 1.9 | $1.2M | 200k | 6.16 | |
| Ritter Pharmaceuticals | 1.7 | $1.1M | 802k | 1.42 | |
| Neurotrope Inc equity | 1.3 | $867k | 45k | 19.10 | |
| Aldeyra Therapeutics (ALDX) | 0.9 | $621k | 124k | 5.00 | |
| Caladrius Biosciences Ord | 0.9 | $593k | 118k | 5.03 | |
| Evoke Pharma | 0.8 | $543k | 175k | 3.10 | |
| Advaxis | 0.8 | $500k | 113k | 4.44 | |
| Amicus Therapeutics (FOLD) | 0.5 | $357k | 50k | 7.14 |
